Sign in

CIK 0001846253

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

OmniAb, Inc.

Sign in to watch
Ticker
OABI
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-250-7800
Business address
5980 HORTON STREET, SUITE 600, EMERYVILLE, CA, 94608
Former names
Avista Public Acquisition Corp. II

Securities

  • OABI Common Stock Nasdaq
  • OABIW Warrant Nasdaq
  1. 4 Exercise or conversion Director acquired 13,172 shares (option exercise)
  2. 4 Open-market sale Chief Legal Officer sold 8,044 shares at $1.96 ($15,766)
  3. 4 Open-market sale Executive VP, Finance and CFO sold 23,922 shares at $1.96 ($46,887)
  4. 4 Open-market sale President and CEO sold 13,666 shares at $1.96 ($26,785)
  5. 4 Open-market buy Director bought 77,261 shares at an average $1.39 ($107,707)
  6. 4 Exercise or conversion Director acquired 17,769 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 13,333 shares (option exercise)
  8. 4 Grant or award President and CEO acquired 540,540 shares (grant or award)
  9. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  10. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  15. 4 Open-market buy Director bought 30,000 shares at $1.52 ($45,600)
  16. 4 Open-market buy Director bought 25,000 shares at $1.46 ($36,500)
  17. 4 Open-market buy Director bought 65,000 shares at $1.44 ($93,600)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 2 of 9 · 174 filings